Pharmaceuticals company Divi's Laboratories announced Q2FY24 & H1FY24 results: Q2FY24: Total income for Q2FY24 increased from Rs 1,935 crore to Rs 1,995 crore in Q2FY23. PBT for Q2FY24 decreased from Rs 615 crore to Rs 469 crore in Q2FY23. PAT for Q2FY24 decreased from Rs 493 crore to Rs 348 crore in Q2FY23. Forex Gain of Rs 11 crore compared to Rs 31 crore in Q2FY23 H1FY24: Total income for H1FY24 decreased from Rs 4,278 crore to Rs 3,854 crore in H1FY23. PAT for H1FY24 decreased from Rs 1,196 crore to Rs 704 crore in H1FY23. Forex Gain of Rs 14 crore compared to Rs 87 crore in H1FY23. Result PDF